hexamethylene bisacetamide and gamma-aminobutyric acid

hexamethylene bisacetamide has been researched along with gamma-aminobutyric acid in 2 studies

*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]

*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Basile, A; Brando, B; Cecchinato, V; Chiaramonte, R; Comi, P; Erba, E; Fazi, C; Scarpati, B1

Other Studies

2 other study(ies) available for hexamethylene bisacetamide and gamma-aminobutyric acid

ArticleYear
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Hexamethylene bisacetamide inhibits malignant phenotype in T-ALL cell lines.
    Leukemia research, 2008, Volume: 32, Issue:5

    Topics: Acetamides; Antineoplastic Agents; Cell Line, Tumor; Cyclin-Dependent Kinase 4; gamma-Aminobutyric Acid; Humans; Leukemia-Lymphoma, Adult T-Cell; Proto-Oncogene Proteins c-bcl-2; Receptor, Notch1; Signal Transduction; Triglycerides; Tumor Suppressor Protein p53

2008